跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XEROL DR 30 duloxetine 30 mg (as hydrochloride) enteric capsule bottle - TGA Drug Approval Details
Approvals
/
TGA
/
XEROL DR 30 duloxetine 30 mg (as hydrochloride) enteric capsule bottle
Approved
STANDARD
XEROL DR 30 duloxetine 30 mg (as hydrochloride) enteric capsule bottle
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a535478d6c4dbb00
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
a535478d6c4dbb00
Product Name
XEROL DR 30 duloxetine 30 mg (as hydrochloride) enteric capsule bottle
Artg Id
199008
Artg Name
XEROL DR 30 duloxetine 30 mg (as hydrochloride) enteric capsule bottle
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2013-07-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a535478d6c4dbb00
Type
Standard
Back to TGA Approvals
